These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 21592394)

  • 1. Effects of 1α,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells.
    Wang WL; Chatterjee N; Chittur SV; Welsh J; Tenniswood MP
    Mol Cancer; 2011 May; 10():58. PubMed ID: 21592394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays.
    Krishnan AV; Shinghal R; Raghavachari N; Brooks JD; Peehl DM; Feldman D
    Prostate; 2004 May; 59(3):243-51. PubMed ID: 15042599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GADD45gamma: a new vitamin D-regulated gene that is antiproliferative in prostate cancer cells.
    Flores O; Burnstein KL
    Endocrinology; 2010 Oct; 151(10):4654-64. PubMed ID: 20739400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of androgen receptor by 1alpha,25-dihydroxyvitamin D3 and 9-cis retinoic acid in LNCaP human prostate cancer cells.
    Zhao XY; Ly LH; Peehl DM; Feldman D
    Endocrinology; 1999 Mar; 140(3):1205-12. PubMed ID: 10067845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,25-Dihydroxyvitamin D3 modulates lipid metabolism in prostate cancer cells through miRNA mediated regulation of PPARA.
    Wang WL; Welsh J; Tenniswood M
    J Steroid Biochem Mol Biol; 2013 Jul; 136():247-51. PubMed ID: 23059473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VDR regulation of microRNA differs across prostate cell models suggesting extremely flexible control of transcription.
    Singh PK; Long MD; Battaglia S; Hu Q; Liu S; Sucheston-Campbell LE; Campbell MJ
    Epigenetics; 2015; 10(1):40-9. PubMed ID: 25494645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activin A regulates microRNAs and gene expression in LNCaP cells.
    Ottley EC; Nicholson HD; Gold EJ
    Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms.
    Zhao XY; Peehl DM; Navone NM; Feldman D
    Endocrinology; 2000 Jul; 141(7):2548-56. PubMed ID: 10875257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1α,25-Dihydroxyvitamin D
    Ben-Eltriki M; Deb S; Guns EST
    J Steroid Biochem Mol Biol; 2021 May; 209():105828. PubMed ID: 33493594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor suppressor microRNAs, miR-100 and -125b, are regulated by 1,25-dihydroxyvitamin D in primary prostate cells and in patient tissue.
    Giangreco AA; Vaishnav A; Wagner D; Finelli A; Fleshner N; Van der Kwast T; Vieth R; Nonn L
    Cancer Prev Res (Phila); 2013 May; 6(5):483-94. PubMed ID: 23503652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor.
    Dunlop TW; Väisänen S; Frank C; Molnár F; Sinkkonen L; Carlberg C
    J Mol Biol; 2005 Jun; 349(2):248-60. PubMed ID: 15890193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of 19-nor-2alpha-(3-hydroxypropyl)-1alpha,25-dihydroxyvitamin D3 as a therapeutic agent for androgen-dependent prostate cancer.
    Flanagan JN; Zheng S; Chiang KC; Kittaka A; Sakaki T; Nakabayashi S; Zhao X; Spanjaard RA; Persons KS; Mathieu JS; Holick MF; Chen TC
    Anticancer Res; 2009 Sep; 29(9):3547-53. PubMed ID: 19667147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1α,25(OH)2D3 differentially regulates miRNA expression in human bladder cancer cells.
    Ma Y; Hu Q; Luo W; Pratt RN; Glenn ST; Liu S; Trump DL; Johnson CS
    J Steroid Biochem Mol Biol; 2015 Apr; 148():166-71. PubMed ID: 25263658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent.
    Zhao XY; Ly LH; Peehl DM; Feldman D
    Endocrinology; 1997 Aug; 138(8):3290-8. PubMed ID: 9231780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D and testosterone co-ordinately modulate intracellular zinc levels and energy metabolism in prostate cancer cells.
    Zhang P; Schatz A; Adeyemi B; Kozminski D; Welsh J; Tenniswood M; Wang WW
    J Steroid Biochem Mol Biol; 2019 May; 189():248-258. PubMed ID: 30664926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells.
    Ikezoe T; Gery S; Yin D; O'Kelly J; Binderup L; Lemp N; Taguchi H; Koeffler HP
    Cancer Res; 2005 Jun; 65(11):4762-8. PubMed ID: 15930295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
    Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
    Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNAs and DICER1 are regulated by 1,25-dihydroxyvitamin D in prostate stroma.
    Dambal S; Giangreco AA; Acosta AM; Fairchild A; Richards Z; Deaton R; Wagner D; Vieth R; Gann PH; Kajdacsy-Balla A; Van der Kwast T; Nonn L
    J Steroid Biochem Mol Biol; 2017 Mar; 167():192-202. PubMed ID: 28089917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer cell type-specific involvement of the VDR and RXR in regulation of the human PTHrP gene via a negative VDRE.
    Sepulveda VA; Weigel NL; Falzon M
    Steroids; 2006 Feb; 71(2):102-15. PubMed ID: 16243370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of fatty acid synthase expression by 1alpha,25-dihydroxyvitamin D3 in prostate cancer cells.
    Qiao S; Pennanen P; Nazarova N; Lou YR; Tuohimaa P
    J Steroid Biochem Mol Biol; 2003 May; 85(1):1-8. PubMed ID: 12798352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.